In this issue:
- CpG HBV vaccine in HIV after nonresponse to conventional vaccine
- Sexual behaviour and STI incidence among MSM on daily and event-driven PrEP
- MI risk among people with HIV
- Adverse perinatal outcomes with different ART classes
- Diabetes risk factors in pitavastatin recipients with HIV
- Outcomes after 12 months of long-acting cabotegravir-rilpivirine vs. bictegravir-emtricitabine-TAF
- Prescription inappropriateness and omissions in older people with HIV
- HIV-1 incidence, adherence and drug resistance with emtricitabine-TDF PrEP
- Switching to dolutegravir lamivudine in virologically suppressed people aged >50 years with HIV
- Mpox-specific immune responses after vaccination or infection in people with HIV
Please login below to download this issue (PDF)